McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
45,000
Employees45,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
45,000
Employees45,000

MCK Key Statistics

Market cap
112.19B
Market cap112.19B
Price-Earnings ratio
27.42
Price-Earnings ratio27.42
Dividend yield
0.32%
Dividend yield0.32%
Average volume
1.13M
Average volume1.13M
High today
$968.61
High today$968.61
Low today
$894.71
Low today$894.71
Open price
$952.00
Open price$952.00
Volume
1.54M
Volume1.54M
52 Week high
$971.93
52 Week high$971.93
52 Week low
$585.23
52 Week low$585.23

Stock Snapshot

The current McKesson(MCK) stock price is $916.00, with a market capitalization of 112.19B. The stock trades at a price-to-earnings (P/E) ratio of 27.42 and offers a dividend yield of 32.1%.

As of 2026-02-12, McKesson(MCK) stock has fluctuated between $894.71 and $968.61. The current price stands at $916.00, placing the stock +2.4% above today's low and -5.4% off the high.

The McKesson(MCK)'s current trading volume is 1.54M, compared to an average daily volume of 1.13M.

In the last year, McKesson(MCK) shares hit a 52-week high of $971.93 and a 52-week low of $585.23.

In the last year, McKesson(MCK) shares hit a 52-week high of $971.93 and a 52-week low of $585.23.

MCK News

Simply Wall St 2d
McKesson Refocuses On North America With Spin Off And Oncology Growth

McKesson (NYSE:MCK) has completed its exit from European operations to focus on North American businesses. The company plans a spin-off of its medical-surgical...

McKesson Refocuses On North America With Spin Off And Oncology Growth
TipRanks 3d
McKesson price target raised to $1,107 from $983 at JPMorgan

JPMorgan analyst Lisa Gill raised the firm’s price target on McKesson (MCK) to $1,107 from $983 and keeps an Overweight rating on the shares. The firm updated t...

Simply Wall St 4d
McKesson Is Up 12.1% After Strong Q3 EPS And Capital Moves Has The Bull Case Changed?

McKesson Corporation recently reported past third-quarter and nine‑month results to December 31, 2025, with sales of US$106.16 billion and net income of US$1.19...

McKesson Is Up 12.1% After Strong Q3 EPS And Capital Moves Has The Bull Case Changed?

Analyst ratings

80%

of 20 ratings
Buy
80%
Hold
15%
Sell
5%

More MCK News

Simply Wall St 6d
Assessing McKesson Valuation After Strong Quarter, Higher Guidance And Business Portfolio Updates

Advertisement Why McKesson’s latest quarter matters for shareholders McKesson (MCK) posted double digit revenue and adjusted EPS growth in its latest quarter,...

Assessing McKesson Valuation After Strong Quarter, Higher Guidance And Business Portfolio Updates
Nasdaq 7d
Thursday Sector Leaders: Healthcare, Utilities

In afternoon trading on Thursday, Healthcare stocks are the best performing sector, higher by 0.2%. Within that group, McKesson Corp (Symbol: MCK) and Cardinal...

Thursday Sector Leaders: Healthcare, Utilities

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.